Chemical Proteomic Characterization of a Covalent KRASG12C Inhibitor.
Ontology highlight
ABSTRACT: The KRASG12C protein product is an attractive, yet challenging, target for small molecule inhibition. One option for therapeutic intervention is to design small molecule ligands capable of binding to and inactivating KRASG12C via formation of a covalent bond to the sulfhydryl group of cysteine 12. In order to better understand the cellular off-target interactions of Compound 1, a covalent KRASG12C inhibitor, we have completed a series of complementary chemical proteomics experiments in H358 cells. A new thiol reactive probe (TRP) was designed and used to construct a cellular target occupancy assay for KRASG12C. In addition, the thiol reactive probes allowed us to profile potential off-target interactions of Compound 1 with over 3200 cysteine residues. In order to complement t
SUBMITTER: Wijeratne A
PROVIDER: S-EPMC6004567 | biostudies-literature | 2018 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA